Why we put our competitors on our SaaS pricing page?

The real reason: reduce buyer risk in a high-stakes medtech purchase

In medtech SaaS, your buyer isn’t just a “user.” It’s often a committee: clinician champion, IT/security, compliance/privacy, procurement, and sometimes revenue cycle. Their default posture is risk-avoidance. A pricing page that pretends alternatives don’t exist forces them to do the comparison work themselves—usually by asking peers, reading forums, or creating an internal spreadsheet that you’ll never see.

When you put competitors on your pricing page (or a linked comparison page), you’re doing two things:

• Lowering perceived risk: “This vendor is confident enough to be compared.”
• Controlling the comparison frame: You guide the buyer toward the criteria that matter in healthcare (workflow fit, integration, security, evidence, reimbursement impact), not just feature checklists.

This is especially powerful in hospital procurement, where the process is designed to justify a decision. If you make the justification easier—without being misleading—you shorten the sales cycle.

What buyers are actually comparing (and why you should surface it)

STEM/clinical founders often assume competitors are compared on “features.” In healthcare, the comparison is usually about implementation friction and institutional safety. Consider highlighting differences in these categories:

• Workflow and adoption: time-to-first-value, training burden, clinician clicks, alert fatigue risk.
• Integration: EHR integration approach (e.g., HL7/FHIR), SSO, audit logs, data export, downtime procedures.
• Security and privacy: HIPAA posture, BAAs, data residency, access controls, SOC 2 status (if applicable), incident response process.
• Clinical/operational evidence: published validation, real-world performance monitoring, IRB-friendly evaluation support (if you run prospective studies).
• Regulatory posture (if relevant): whether your product is regulated as Software as a Medical Device (SaMD) and what pathway applies (510(k), De Novo, PMA) varies by intended use and claims.
• Economic value: how you affect revenue/cost—e.g., documentation time, denials, throughput. If reimbursement is involved, mention whether there are relevant CPT codes or billing workflows (details vary by specialty and payer).

By naming these criteria, you help a buyer build an internal business case. That’s the hidden job your pricing page can do.

When listing competitors helps (and when it backfires)

It helps when you have a clear wedge

A “wedge” is the specific reason a buyer chooses you even if you’re smaller: faster deployment, better integration, narrower clinical focus, better compliance posture, or a pricing model that matches how hospitals buy.

Examples of wedges that work well on pricing pages:

• Implementation speed: “Go live in weeks, not months” (only if you can consistently deliver).
• Transparent packaging: fewer add-ons; clear what’s included (security, audit logs, integrations).
• Specialty depth: “Built for stroke teams” beats “AI for everyone.”

It backfires when you’re not ready for scrutiny

Don’t invite comparisons if your product, security posture, or support capacity can’t withstand due diligence. In medtech, a competitor callout can trigger deeper questions from IT/security and compliance.

Common failure modes:

• Unverifiable claims: “Best accuracy” without context, dataset description, or monitoring plan.
• Regulatory ambiguity: implying FDA clearance when you don’t have it, or blurring “clinical decision support” vs SaMD.
• Pricing mismatch: comparing per-seat SaaS pricing to enterprise contracts without explaining scope differences.

How to do it safely: a medtech-friendly comparison structure

You can “put competitors on the pricing page” in two common ways:

1. Inline comparison block: a small section under pricing tiers: “Compare us to X / Y.”
2. Linked comparison pages: your pricing page links to dedicated pages (e.g., “Us vs Competitor A”). This is usually cleaner for SEO and compliance review.

For medtech, the linked approach is often safer because you can add nuance and disclaimers without cluttering pricing.

A practical template for the comparison table

Use a table that emphasizes procurement-relevant criteria. Keep it factual and avoid subjective language like “best,” “leading,” or “#1.”

Important: only include competitor facts you can source from their public materials or what customers can reasonably verify. If you’re unsure, say “not publicly specified.”

Compliance and legal guardrails (non-negotiable in healthcare)

• Avoid misleading clinical claims: If you mention outcomes, be clear about evidence type (pilot, retrospective, prospective) and context. Don’t imply generalizability you haven’t proven.
• Be careful with FDA language: If you are cleared/authorized, state exactly what and for what intended use. If not, don’t hint. Pathway (510(k), De Novo, PMA) depends on classification and claims.
• Don’t disclose confidential pricing: Many enterprise deals have negotiated terms. Compare packaging and value drivers, not rumored dollar amounts.
• Use reviewable wording: Write it so your legal/compliance reviewer can approve it quickly: factual, sourced, and scoped.

Why it works commercially: positioning, qualification, and faster procurement

Competitor visibility on pricing pages is a positioning move. Positioning is the “category and context” you want to be evaluated in. If you don’t define it, the buyer will—often incorrectly.

Done well, competitor comparisons create three business benefits:

• Self-qualification: Buyers who need what you’re best at will lean in; buyers who want a different approach will opt out earlier (saving you sales time).
• Shorter evaluation cycles: You pre-answer common procurement questions (security, integration, governance), reducing back-and-forth.
• Higher trust: Transparency signals maturity—critical when hospitals worry about vendor stability and support.

A subtle but important medtech angle: if your product touches reimbursement or operational metrics, your comparison should help a buyer map to their internal stakeholders (clinical leadership, IT, compliance, revenue cycle). That alignment is often what gets you through committees.

What to do next

1. List your top 3 competitors and your wedge: write one sentence per competitor: “They win when ___; we win when ___.”
2. Draft a procurement-first comparison table: include integration, security/privacy, governance, implementation steps, and commercial model—avoid feature bloat.
3. Create one “Us vs X” page and link it from pricing: keep the pricing page clean; put nuance and disclaimers on the comparison page.
4. Run a compliance pass: verify every competitor statement is sourced; tighten FDA/clinical language to match your intended use and evidence.
5. Test with 5 target buyers: ask a clinician champion and an IT/security person: “What’s missing for you to recommend this internally?”

If you want a structured way to map competitors and messaging before you publish, use /Competitor_study and then pressure-test your pricing narrative with /roast.